We have investigated the pathological correlates of dementia in the brains from a
consecutive series of 70 patients dying with a clinical diagnosis of frontotemporal lobar …

We have investigated the extent and pattern of immunostaining for ubiquitin protein (UBQ) in
60 patients with frontotemporal lobar degeneration (FTLD) with ubiquitin-positive, tau …

Although immunohistochemistry has helped to classify the histology of frontotemporal lobar
degeneration (FTLD), there have been many cases, described in the literature as showing …

Frontotemporal lobar degeneration (FTLD) encompasses a heterogeneous group of clinical
syndromes that include frontotemporal dementia (FTD), frontotemporal dementia with motor …

One year ago, in this journal, we published a recommended nomenclature for the
neuropathologic subtypes of frontotemporal lobar degeneration (FTLD)[7]. A major impetus …

The aim of this study was to improve the neuropathologic recognition and provide criteria for
the pathological diagnosis in the neurodegenerative diseases grouped as frontotemporal …

Frontotemporal lobar degeneration (FTLD) without tau pathology is clinically and
pathologically heterogeneous. The present report describes the neuropathology of 52 brains …

In 2006, two papers were published, each describing pathological heterogeneity in cases of
frontotemporal lobar degeneration (FTLD) with ubiquitin-positive, tau-negative inclusions …

Frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U) is a common
neuropathological subtype of frontotemporal dementia. Although this subtype of …

We set out to determine the frequency of the different pathologies underlying frontotemporal
degeneration (FTD) in our brain bank series, by reviewing all cases of pathologically …